Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion.
about
Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultryp53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responsesClinical applications of attenuated MVA poxvirus strain.Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab.
P2860
Recombinant modified vaccinia virus ankara (MVA) expressing wild-type human p53 induces specific antitumor CTL expansion.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Recombinant modified vaccinia ...... cific antitumor CTL expansion.
@ast
Recombinant modified vaccinia ...... cific antitumor CTL expansion.
@en
type
label
Recombinant modified vaccinia ...... cific antitumor CTL expansion.
@ast
Recombinant modified vaccinia ...... cific antitumor CTL expansion.
@en
prefLabel
Recombinant modified vaccinia ...... cific antitumor CTL expansion.
@ast
Recombinant modified vaccinia ...... cific antitumor CTL expansion.
@en
P2093
P2860
P1433
P1476
Recombinant modified vaccinia ...... ecific antitumor CTL expansion
@en
P2093
Guang-Yun Song
Hidenobu Ishizaki
Joshua D I Ellenhorn
Simon F Lacey
Tumul Srivastava
P2860
P304
P356
10.3109/07357907.2011.606248
P577
2011-08-15T00:00:00Z